Hutch News
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Jenny Hansen: Two-time survivor, first-time Obliterider
‘I am so thankful there are people out there who aren’t afraid of cancer, who pursue it’
Timmerman headed for the top, again, with friends
Hutch expedition to Kilimanjaro has already raised $1 million
.JPG)
Dr. Holly Harris receives 2 grants to research endometriosis
Hutch public health researcher receives nearly $1.5 million to study endometriosis pain as well as the condition's connection to ovarian cancer
Dr. Kristin Anderson receives research grant from Ovarian Cancer Research Alliance
Anderson will use funds to expand research in boosting anti-tumor immune responses
When worry drives behavior
From M. Robyn Andersen, Public Health Sciences Division
Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer
5 questions with a cancer immunotherapy expert
Dr. Phil Greenberg to receive high honor for his contributions to the field
Squelching ovarian cancer: the not-so-silent killer
The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease
Endometriosis linked to childhood abuse
New Fred Hutch collaboration highlights yet another poor health outcome associated with adverse childhood experiences
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers
Dr. Goldie Lui receives funding from Ovarian Cancer Research Alliance
Celebrating faculty and staff achievements
Invasive ovarian cancer risk: understanding the role of the menstrual cycle
From the Harris Group, Public Health Sciences Division
The latest in gynecological cancer research from the Pacific Northwest
Inaugural Northwest Gynecological Cancer Symposium brings together scientists studying ovarian, cervical and endometrial cancers
Good News: Mustang Bio licenses Fred Hutch CD20 CAR-T immunotherapy for lymphoma trial
Celebrating faculty and staff achievements
The tumor microenvironment: How cancer fools healthy neighboring cells
‘Tumor microenvironment’ research underscores why we need cancer immunotherapy — and how to make it work for more patients
Good News: Fred Hutch scientists to develop bioassay for ovarian cancer for new NCI initiative
Celebrating faculty and staff achievements
The NKG2D paradox in ovarian cancer development
from the Spies lab (Clinical Research Division)
Good News: 8 Fred Hutch/UW researchers receive pilot awards
Celebrating faculty and staff achievements
Dissolving implant could bring immunotherapy to solid tumors
A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study
Immunotherapy for ovarian cancer shows promise in mouse model, but hurdles remain
‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors
Finding ways to deliver on the promise of precision oncology
‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients
B56-PP2A takes the cycle out of cyclin E
From the Clurman Lab (Human Biology and Clinical Research Divisions)